Skip to main content

Animations

MJFF Publications

781 - 790 of 8580 Results
Title
Year
  • Year
  • 2019
  • 2019
  • 2014
  • 2014
  • 2015
  • 2025
  • 2021
  • 2022
  • 2019
  • 2019
  • Summary Details
    OPEN
    Title: Transportation innovation to aid Parkinson disease trial recruitment
    Journal Name: Contemporary Clinical Trials Communications
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.conctc.2019.100449
    Citation Count: 9
  • Summary Details
    RESTRICTED
    Title: Hypertension and progressive supranuclear palsy
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.07.036
    Best OA location URL:
    Citation Count: 19
  • Summary Details
    OPEN
    Title: Comparison of voluntary and reflex cough effectiveness in Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2014.09.010
    Citation Count: 46
  • Summary Details
    OPEN
    Title: Concomitant pathologies among a spectrum of parkinsonian disorders
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2014.02.012
    Citation Count: 141
  • Summary Details
    RESTRICTED
    Title: Intracellular Target-Specific Accretion of Cell Penetrating Peptides and Bioportides: Ultrastructural and Biological Correlates
    Journal Name: Bioconjugate Chemistry
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1021/acs.bioconjchem.5b00529
    Best OA location URL:
    Citation Count: 17
  • Summary Details
    RESTRICTED
    Title: PPM1M, an LRRK2-counteracting, phosphoRab12-preferring phosphatase with a potential link to Parkinson’s disease
    Journal Name: Cell Reports
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.celrep.2025.116031
    Citation Count: 0
  • Summary Details
    OPEN
    Title: PDKit: A data science toolkit for the digital assessment of Parkinson’s Disease
    Journal Name: PLOS Computational Biology
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pcbi.1008833
    Citation Count: 5
  • Summary Details
    RESTRICTED
    Title: Site-Specific Phospho-Tau Aggregation-Based Biomarker Discovery for AD Diagnosis and Differentiation
    Journal Name: ACS Chemical Neuroscience
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1021/acschemneuro.2c00342
    Citation Count: 11
  • Summary Details
    OPEN
    Title: miR-34a: a new player in the regulation of T cell function by modulation of NF-κB signaling
    Journal Name: Cell Death & Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41419-018-1295-1
    Citation Count: 67
  • Summary Details
    OPEN
    Title: Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH‐EXAMINER as a potential clinical trial endpoint
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.jalz.2019.01.012
    Citation Count: 40
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.